UKRI Funding for early stage development of new healthcare interventions:
Apply for funding to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test, or other medical intervention development.

The idea for a new product that can improve human health should have already been conceived and supported by other funding. This should be utilised to produce the critical preliminary data needed to support the onward development of the product.

You can apply for funding for work on novel:

• new small molecule medicines
• vaccines for infectious or non-infectious disease
• biologics (antibodies, peptides, proteins)
• advanced therapeutics (for example, gene therapy, cell therapy, RNA therapy, nucleic acid therapy and T-cell therapy)
• complex medicines for example PROTACS, molecular glues and antibody-drug conjugates
• regenerative medicine approaches
• repurposing clinical studies or using existing therapies for new indications
• medical devices
• digital healthcare, app development or artificial intelligence
• diagnostics (including biomarker validation)
• medical imaging technology
• surgical techniques or tools
• behavioural and psychological interventions
• radiotherapy and radiation protocols